Clinical Trial Update: Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta

View source ↗

Summary

Ongoing clinical study focusing on multi-omics and neuroclinical insights for hereditary ataxia in the Yangtze Delta region; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Ataxia

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Hereditary Ataxia | Status: RECRUITING